Real estate remains one of the most closely watched corners of the U.S. equity market, and investors seeking sector exposure often weigh breadth against thematic precision. The IYR (iShares U.S. Real Estate ETF) and NURE (Nuveen Short-Term REIT ETF) both fall within the real estate category, yet they are not direct substitutes. IYR captures the entire investable U.S. REIT universe, while NURE deliberately concentrates on property types with shorter lease durations that can reprice rents more quickly. This ETF comparison clarifies how structural differences, sector exposure, and relative positioning shape each fund's risk-and-return profile in the current rate-sensitive environment.
Launched in 2000 by BlackRock, IYR is a passively managed fund that seeks to track the Dow Jones U.S. Real Estate Capped Index, a market-capitalization-weighted benchmark of U.S. real estate equities. The fund holds roughly 62 securities and provides diversified access across nearly every property segment, with effectively all of its assets (about 99.5%) allocated to real estate. Its expense ratio is approximately 0.37%.
Top holdings are dominated by large-cap operators, including WELL (Welltower), PLD (Prologis), AMT (American Tower), SPG (Simon Property), EQIX (Equinix), DLR (Digital Realty), O (Realty Income), PSA (Public Storage), and VTR (Ventas). Its scale and daily trading volume give it a deep liquidity profile, and its broad weighting across healthcare, industrial, data-center, tower, retail, residential, and storage REITs make it a comprehensive real-estate barometer.
NURE is a passively managed thematic fund launched in 2016 that tracks the Dow Jones U.S. Select Short-Term REIT Index. The strategy invests in equity REITs with shorter-than-average lease durations, concentrating on apartments, hotels, self-storage, single-family rental, and manufactured-housing properties that can adjust pricing more rapidly. With roughly 30 holdings, an expense ratio of about 0.36%, and float-adjusted market-cap weighting (with individual holdings capped around 5% at each rebalance), NURE is classified as non-diversified and carries higher concentration risk than broader peers.
Key positions include RHP (Ryman Hospitality), HST (Host Hotels), INVH (Invitation Homes), AMH (American Homes 4 Rent), ESS (Essex Property), CPT (Camden Property), EQR (Equity Residential), PSA (Public Storage), CUBE (CubeSmart), and UDR. Its assets under management (AUM) are considerably smaller than IYR's, which translates into thinner trading volume and a less robust liquidity profile.
U.S. real estate investment trusts sit at the intersection of macroeconomic and capital-markets forces. Interest-rate expectations remain the dominant driver, because higher borrowing costs raise REIT financing expenses and compress property valuations, while falling yields tend to support the sector. Within this backdrop, shorter-lease operators such as hotels, apartments, and self-storage have historically demonstrated greater pricing power during inflationary periods, as they can reprice rents and room rates more frequently. By contrast, long-duration segments such as triple-net, office, and certain industrial leases reprice more slowly.
Structural themes also matter: the growth of data centers and telecommunications towers has favored technology-adjacent REITs, while demographic shifts and constrained housing supply support residential operators. These catalysts create divergent performance patterns within the sector, favoring diversified vehicles in some cycles and focused strategies in others.
In recent weeks and months, the two funds have reflected their differing sector exposures. IYR's heavier tilt toward data-center, tower, and industrial names has allowed it to benefit from secular technology and logistics demand, while also carrying interest-rate sensitivity across its broad portfolio. NURE's concentration in apartments, hotels, and storage has been shaped by consumer spending, travel activity, and rental-market fundamentals, giving it a distinct performance driver set.
From a relative positioning standpoint, NURE's narrower footprint can magnify both gains and losses in any single property type, whereas IYR's diversification tends to smooth idiosyncratic swings. NURE also trades with notably lower average daily volume, which can widen bid-ask spreads and elevate transaction costs for larger orders. These liquidity and volatility differences are central to evaluating how each fund behaves across changing market cycles.
Tickeron's AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market using technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of securities with customizable filters for industry, market capitalization, technical indicators, price patterns, and performance metrics, helping surface trade ideas, trending names, breakout candidates, and market opportunities more efficiently than manual screening. Explore the AI Screener to identify real estate and other sector opportunities aligned with your strategy.
Based on observable structural factors, Tickeron's AI would likely favor IYR over NURE in the current environment. IYR offers broader sector capture, materially greater liquidity, and superior diversification, which reduces exposure to any single property type or holding. While NURE's lower expense ratio and short-lease pricing power are legitimate advantages, its small asset base, non-diversified structure, and concentration in a handful of cyclical segments introduce incremental volatility and liquidity risk. An AI-driven framework weighing diversification profile, trend consistency, and structural stability would most likely identify IYR as the more robust relative choice, though this reflects a probabilistic assessment rather than personalized investment advice.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The 50-day moving average for IYR moved below the 200-day moving average on October 22, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
The 10-day RSI Indicator for IYR moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 28 similar instances where the indicator moved out of overbought territory. In 24 of the 28 cases, the stock moved lower in the following days. This puts the odds of a move lower at 86%.
The Momentum Indicator moved below the 0 level on November 17, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IYR as a result. In 67 of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 80%.
The Moving Average Convergence Divergence Histogram (MACD) for IYR turned negative on November 17, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 39 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 83%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IYR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.
IYR broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
IYR moved above its 50-day moving average on October 29, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for IYR crossed bullishly above the 50-day moving average on November 02, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 14 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 78%.
Following a +1.44% 3-day Advance, the price is estimated to grow further. Considering data from situations where IYR advanced for three days, in 255 of 309 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
The Aroon Indicator entered an Uptrend today. In 224 of 298 cases where IYR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 75%.
The 10-day moving average for NURE crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 17 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 89%.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
NURE moved above its 50-day moving average on October 16, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +0.74% 3-day Advance, the price is estimated to grow further. Considering data from situations where NURE advanced for three days, in 245 of 306 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
The Aroon Indicator entered an Uptrend today. In 180 of 253 cases where NURE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 71%.
The 10-day RSI Indicator for NURE moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 26 similar instances where the indicator moved out of overbought territory. In 22 of the 26 cases, the stock moved lower in the following days. This puts the odds of a move lower at 85%.
The Momentum Indicator moved below the 0 level on November 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on NURE as a result. In 63 of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 75%.
The Moving Average Convergence Divergence Histogram (MACD) for NURE turned negative on November 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 36 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 77%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NURE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
NURE broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
| IYR | NURE | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 86% | 2 days ago 85% |
| Stochastic ODDS (%) | 2 days ago 85% | 2 days ago 75% |
| Momentum ODDS (%) | 2 days ago 80% | 2 days ago 75% |
| MACD ODDS (%) | 2 days ago 83% | 2 days ago 77% |
| TrendWeek ODDS (%) | 2 days ago 80% | 2 days ago 81% |
| TrendMonth ODDS (%) | 2 days ago 79% | 2 days ago 80% |
| Advances ODDS (%) | 18 days ago 83% | 4 days ago 80% |
| Declines ODDS (%) | 3 days ago 85% | 8 days ago 84% |
| BollingerBands ODDS (%) | 2 days ago 78% | 2 days ago 74% |
| Aroon ODDS (%) | 2 days ago 75% | 2 days ago 71% |
A.I.dvisor indicates that over the last year, NURE has been closely correlated with UDR. These tickers have moved in lockstep 83% of the time. This A.I.-generated data suggests there is a high statistical probability that if NURE jumps, then UDR could also see price increases.
| Ticker / NAME | Correlation To NURE | 1D Price Change % | ||
|---|---|---|---|---|
| NURE | 100% | +0.03% | ||
| UDR - NURE | 83% Closely correlated | +0.03% | ||
| MAA - NURE | 82% Closely correlated | -0.68% | ||
| CPT - NURE | 80% Closely correlated | -0.32% | ||
| ESS - NURE | 76% Closely correlated | +1.06% | ||
| VMRK - NURE | 75% Closely correlated | -0.78% | ||
More | ||||